Corticotropin-releasing factor: Innocent until proven guilty

Nature Reviews Neuroscience

Volumn 13, Issue 1, 2012, Pages 70-

  Giardino, William J ^a   Ryabinin, Andrey E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; UROCORTIN;

ADDICTION; ALCOHOL CONSUMPTION; ALCOHOLISM; BEHAVIOR; HORMONE BINDING; LETTER; MEDIAN RAPHE NUCLEUS; PHENOTYPE; PRIORITY JOURNAL;

ALCOHOLISM; HUMANS; PHARMACOGENETICS; RECEPTORS, OPIOID;

EID: 84055192238     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn3110-c1     Document Type: Letter

References (10)

1. Heilig, M., Goldman, D., Berrettini, W. & O'Brien, C. P. Pharmacogenetic approaches to the treatment of alcohol addiction. Nature Rev. Neurosci. 12, 670-684 (2011).
2. Reul, J. M. & Holsboer, F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2, 23-33 (2002).
3. Le, A. D., Harding, S., Juzytsch, W., Fletcher, P. J. & Shaham, Y. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J. Neurosci. 22, 7844-7849 (2002). (Pubitemid 35390354)
4. Perrin, M. H., Sutton, S. W., Cervini, L. A., Rivier, J. E. & Vale, W. W. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J. Pharmacol. Exp. Ther. 288, 729-734 (1999). (Pubitemid 29119688)
5. Bittencourt, J. C. et al. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J. Comp. Neurol. 415, 285-312 (1999).
6. Deussing, J. M. et al. Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. J. Neurosci. 30, 9103-9116 (2010).
7. Sharpe, A. L. & Phillips, T. J. Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice. Behav. Pharmacol. 20, 346-351 (2009).
8. Funk, C. K. & Koob, G. F. A CRF2 agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res. 1155, 172-178 (2007). (Pubitemid 46900928)
9. Lowery, E. G. & Thiele, T. E. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism. CNS Neurol. Disord. Drug Targets 9, 77-86 (2010).
10. Giardino, W. J., Cocking, D. L., Kaur, S., Cunningham, C. L. & Ryabinin, A. E. Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference. PLoS ONE 6, e26997 (2011).